Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00918866Phase 4Completed
A Phase 4 trial of perflutren lipid microspheres, sponsored by Lantheus Holdings, Inc.. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00918866.